Integrated compliance monitoring across all portfolios

Atara Biotherapeutics

Atara Biotherapeutics is a biopharmaceutical company heavily focused on research and development. Their portfolio of more than $300 million in AUM includes corporate debt, asset-backed securities, government debt, and more.

• Headquarters Thousand Oaks, California
• Assets Under Management $300M
• Website https//www.atarabio.com/

With Clearwater’s automated, scalable, and flexible reporting, Atara now has a singular, transparent view into all their accounts, allowing them to focus on new growth opportunities without necessitating a larger treasury team.

• $300 million in AUM
• 1 dashboard to view all portfolio holdings
• 360 degree view of investment operations

Challenges

• Pursuing rapid growth while maintaining a lean headcount
• Needed to file SEC disclosures after going public
• Struggled with disparate data and an inability to compare managers

Results

• Consolidation of separately managed accounts under one login for a transparent view of the portfolio
• Flexible and customizable reporting for SEC disclosures, general ledger automation, and compliance
• Scalability to accommodate investment growth without additional treasury personnel

“Consolidating with Clearwater allows us to see all our portfolio holdings in one view. We can compare managers and strategies in ways we couldn’t before. Because of the automation, we are able to keep a lean treasury team, while pursuing new growth strategies.”

Tina Gullotta, Directory of Treasury, Atara Biotherapeutics